Stephen Jaeger
Direttore Tecnico/Scientifico/R&S presso TRAUMHAUS AG
Provenienza dei contatti di primo grado di Stephen Jaeger
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 14 | |
11
| Public Company | Homebuilding | 11 |
| Extinct | Pharmaceuticals: Major | 4 | |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments
4
| Extinct | Medical Specialties | 4 |
eBT International, Inc.
1
| Extinct | Packaged Software | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Stephen Jaeger tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC. | Medical Specialties | Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| LADRX CORPORATION | Biotechnology | Founder Director of Finance/CFO | |
| GERON CORPORATION | Biotechnology | Director/Board Member | |
| MEDICIS PHARMACEUTICAL CORP | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Corporate Officer/Principal | |
| BIONOVO INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
MiMedx Processing Services LLC
 MiMedx Processing Services LLC Medical SpecialtiesHealth Technology MiMedx Processing Services LLC provides products that improve the lives of patients suffering from back pain. The company was founded on June 27, 2007 and is headquartered in Marietta, GA. | Medical Specialties | Founder Director of Finance/CFO | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Founder Chief Executive Officer | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
DemeRx, Inc.
 DemeRx, Inc. BiotechnologyHealth Technology DemeRx, Inc. provides biotechnology services. It focuses on drug addiction among patients coping with chronic pain. The company was founded by Deborah C. Mash on March 1, 2010 and is headquartered in Miami, FL. | Biotechnology | Chairman Director of Finance/CFO | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
| BIEN ZENKER AG | Homebuilding | Corporate Officer/Principal Corporate Officer/Principal | |
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Graduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Masters Business Admin | |
| Washington State University | College/University | Doctorate Degree | |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member | |
| De Montfort University | College/University | Undergraduate Degree | |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
SteadyMed Therapeutics, Inc.
 SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA. | Medical/Nursing Services | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| WomenWeb AG | Chairman Chief Executive Officer | ||
| CLEARPOINT NEURO, INC. | Medical Specialties | Founder Director of Finance/CFO | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| INNOVEREN SCIENTIFIC INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
ReForm Biologics LLC
 ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| ABSCI CORPORATION | Biotechnology | Director/Board Member | |
Tspan LLC
 Tspan LLC Pharmaceuticals: MajorHealth Technology Tspan LLC is an American pharmaceutical manufacturing company. The private company is based in New York. | Pharmaceuticals: Major | Director/Board Member | |
Cerebral Therapeutics, Inc.
 Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Miscellaneous Commercial Services | Chairman | |
Tevard Biosciences, Inc.
 Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017. | Miscellaneous Commercial Services | Director/Board Member | |
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director of Finance/CFO | |
Itero Holdings LLC
 Itero Holdings LLC Financial ConglomeratesFinance Itero Holdings LLC provides investment services. The private company is based in San Jose, CA. | Financial Conglomerates | Chief Executive Officer | |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Pharmaceuticals: Major | Director/Board Member | |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MIMEDX GROUP, INC. | Medical Specialties | Founder Director of Finance/CFO | |
Itero Biopharmaceuticals LLC
 Itero Biopharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Itero Biopharmaceuticals LLC provides royalty payment services for licensing agreements. The American company was founded by V. Bryan Lawlis. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Welsh School of Pharmacy | College/University | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 45 |
| Germania | 3 |
| Regno Unito | 3 |
| Svezia | 2 |
| Israele | 2 |
Settori
| Health Technology | 34 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Communications | 3 |
| Finance | 3 |
Posizioni
| Director/Board Member | 138 |
| Corporate Officer/Principal | 42 |
| Director of Finance/CFO | 41 |
| Founder | 38 |
| Independent Dir/Board Member | 37 |
Contatti più connessi
| Insiders | |
|---|---|
| Steven Gorlin | 37 |
| John Thomas | 30 |
| Bobba Venkatadri | 24 |
| Markus W. Wenner | 23 |
| V. Lawlis | 21 |
| Edward I. Terino | 18 |
| Jonathan Rigby | 16 |
| Timothy Patrick Lynch | 16 |
| John Siebert | 16 |
| Stephen Farr | 16 |
| Dennis L. Winger | 15 |
| Daniel P. Maher | 11 |
| Richard P. Thompson | 10 |
| Maximillian D. Fiore | 9 |
| Peter D. Noymer | 8 |
- Borsa valori
- Insiders
- Stephen Jaeger
- Connessioni Società
